- Report
- August 2022
- 118 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
- 116 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2021
- 100 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 140 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- September 2023
- 143 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- September 2022
- 148 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- March 2019
- 104 Pages
Global
From €4088EUR$4,300USD£3,434GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2024
- 80 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 186 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 172 Pages
Global
From €4278EUR$4,500USD£3,594GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- July 2024
- 110 Pages
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 114 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 114 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4516EUR$4,750USD£3,794GBP
- Report
- June 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2023
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more